BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16894333)

  • 1. Lidocaine pharmacokinetics in postmenopausal women on hormone therapy.
    Gawronska-Szklarz B; Zarzycki M; Musial HD; Pudlo A; Loniewski I; Drozdzik M
    Menopause; 2006; 13(5):793-8. PubMed ID: 16894333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):120-3. PubMed ID: 15447735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus.
    Moisés EC; Duarte Lde B; Cavalli Rde C; Marques MP; Lanchote VL; Duarte G; da Cunha SP
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1189-96. PubMed ID: 18679666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause.
    Casanova G; dos Reis AM; Spritzer PM
    Climacteric; 2015 Feb; 18(1):86-93. PubMed ID: 25017924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.
    Mirkin S; Amadio JM; Bernick BA; Pickar JH; Archer DF
    Maturitas; 2015 May; 81(1):28-35. PubMed ID: 25835751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial.
    Scarabin PY; Alhenc-Gelas M; Oger E; Plu-Bureau G
    Thromb Haemost; 1999 May; 81(5):673-5. PubMed ID: 10365734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.
    Smith GI; Reeds DN; Okunade AL; Patterson BW; Mittendorfer B
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1306-10. PubMed ID: 24694337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone.
    Honisett SY; Stojanovska L; Sudhir K; Kingwell BA; Dawood T; Komesaroff PA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4615-9. PubMed ID: 15356071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.